Cargando…

Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae

BACKGROUND: Haemophilus influenzae is found in the nasopharynx of 80% of the human population. While colonisation with non-typeable Haemophilus influenzae (NTHi) is usually asymptomatic, it is capable of causing acute and chronic otitis media (OM) in infants, invasive disease in susceptible groups a...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Stephen R., Leung, Stephanie, Knox, Katy, Wilkinson, Tom M. A., Staples, Karl J., Lestrate, Pascal, Wauters, Dominique, Gorringe, Andrew, Taylor, Stephen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206646/
https://www.ncbi.nlm.nih.gov/pubmed/30373523
http://dx.doi.org/10.1186/s12866-018-1314-5
_version_ 1783366389378056192
author Thomas, Stephen R.
Leung, Stephanie
Knox, Katy
Wilkinson, Tom M. A.
Staples, Karl J.
Lestrate, Pascal
Wauters, Dominique
Gorringe, Andrew
Taylor, Stephen C.
author_facet Thomas, Stephen R.
Leung, Stephanie
Knox, Katy
Wilkinson, Tom M. A.
Staples, Karl J.
Lestrate, Pascal
Wauters, Dominique
Gorringe, Andrew
Taylor, Stephen C.
author_sort Thomas, Stephen R.
collection PubMed
description BACKGROUND: Haemophilus influenzae is found in the nasopharynx of 80% of the human population. While colonisation with non-typeable Haemophilus influenzae (NTHi) is usually asymptomatic, it is capable of causing acute and chronic otitis media (OM) in infants, invasive disease in susceptible groups and is the leading cause of exacerbations of patients with chronic obstructive pulmonary disease (COPD). Current methods for assessing functional antibody immunity to NTHi are limited and labour intensive. Flow cytometric assays could provide an attractive alternative to evaluate immune responses to candidate vaccines in clinical trials. RESULTS: We have developed a duplexed flow-cytometric uptake and oxidative burst opsonophagocytosis assay (fOPA). We have also developed a duplexed antibody-mediated complement C3b/iC3b and C5b-9 deposition assay (CDA). Antibody-mediated C3b/iC3b deposition correlated with opsonophagocytic uptake (r = 0.65) and with opsonophagocytic oxidative burst (r = 0.69). Both fOPA and CDA were reproducible, with the majority of samples giving a coefficient of variation (CV) of < 20% and overall assay CVs of 14% and 16% respectively. CONCLUSIONS: The high-throughput flow cytometric assays developed here were successfully optimised for use with NTHi. Assays proved to be sensitive and highly reproducible for the measurement of bacterial uptake and oxidative burst opsonophagocytosis and antibody-mediated deposition of C3b/iC3b and C5b-9. These assays are useful tools for use in large scale epidemiological studies and to assist in the assessment of functional antibody induced by NTHi candidate vaccines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12866-018-1314-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6206646
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62066462018-10-31 Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae Thomas, Stephen R. Leung, Stephanie Knox, Katy Wilkinson, Tom M. A. Staples, Karl J. Lestrate, Pascal Wauters, Dominique Gorringe, Andrew Taylor, Stephen C. BMC Microbiol Methodology Article BACKGROUND: Haemophilus influenzae is found in the nasopharynx of 80% of the human population. While colonisation with non-typeable Haemophilus influenzae (NTHi) is usually asymptomatic, it is capable of causing acute and chronic otitis media (OM) in infants, invasive disease in susceptible groups and is the leading cause of exacerbations of patients with chronic obstructive pulmonary disease (COPD). Current methods for assessing functional antibody immunity to NTHi are limited and labour intensive. Flow cytometric assays could provide an attractive alternative to evaluate immune responses to candidate vaccines in clinical trials. RESULTS: We have developed a duplexed flow-cytometric uptake and oxidative burst opsonophagocytosis assay (fOPA). We have also developed a duplexed antibody-mediated complement C3b/iC3b and C5b-9 deposition assay (CDA). Antibody-mediated C3b/iC3b deposition correlated with opsonophagocytic uptake (r = 0.65) and with opsonophagocytic oxidative burst (r = 0.69). Both fOPA and CDA were reproducible, with the majority of samples giving a coefficient of variation (CV) of < 20% and overall assay CVs of 14% and 16% respectively. CONCLUSIONS: The high-throughput flow cytometric assays developed here were successfully optimised for use with NTHi. Assays proved to be sensitive and highly reproducible for the measurement of bacterial uptake and oxidative burst opsonophagocytosis and antibody-mediated deposition of C3b/iC3b and C5b-9. These assays are useful tools for use in large scale epidemiological studies and to assist in the assessment of functional antibody induced by NTHi candidate vaccines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12866-018-1314-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-29 /pmc/articles/PMC6206646/ /pubmed/30373523 http://dx.doi.org/10.1186/s12866-018-1314-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology Article
Thomas, Stephen R.
Leung, Stephanie
Knox, Katy
Wilkinson, Tom M. A.
Staples, Karl J.
Lestrate, Pascal
Wauters, Dominique
Gorringe, Andrew
Taylor, Stephen C.
Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae
title Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae
title_full Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae
title_fullStr Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae
title_full_unstemmed Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae
title_short Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae
title_sort development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable haemophilus influenzae
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206646/
https://www.ncbi.nlm.nih.gov/pubmed/30373523
http://dx.doi.org/10.1186/s12866-018-1314-5
work_keys_str_mv AT thomasstephenr developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae
AT leungstephanie developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae
AT knoxkaty developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae
AT wilkinsontomma developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae
AT stapleskarlj developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae
AT lestratepascal developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae
AT wautersdominique developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae
AT gorringeandrew developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae
AT taylorstephenc developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae